Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated ...
New treatments are in development for inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. Find out what ...
Positive results from the CLARITY-Gastric01 global Phase III trial showed AstraZeneca’s sonesitatug vedotin (Sone-Ve) demonstrated a statistically significant and highly clinically meaningful ...
Danny Rischin, MD, on C-POST trial findings on prognostic value of ctDNA and DFS with adjuvant cemiplimab in high-risk CSCC.
Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, ...
RELATIVITY-047's 5-year survival data and LAG-3-high CD8+ T cell biomarker findings signal a shift in how immuno-oncology ...
The smart ring category has evolved from an experimental subsegment of personal wellness hardware into a fiercely contested ...
Tarlatamab plus durvalumab extends survival. However, the 'starting point for measurement' is crucialConfirmed on October 25, ...
Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI ...
Missing blood pressure medication could mean losing much of its protection against heart attacks and strokes, according to an ...
Oceana Hayes addressed Judge Evan Jones in a warm, wood-paneled courtroom in Whatcom County. Her voice clear and sharp, Hayes ...
With net assets of 129 billion yen for the fiscal year ending June 2025, how was Trial HD able to go out and acquire Seiyu by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results